Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Review and Consensus on Pharmacogenomic Testing in Psychiatry
Chad A. Bousman, Susanne Bengesser, Katherine J. Aitchison, et al.
Pharmacopsychiatry (2020) Vol. 54, Iss. 01, pp. 5-17
Open Access | Times Cited: 148

Showing 1-25 of 148 citing articles:

ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG)
David T. Miller, Kristy Lee, Wendy K. Chung, et al.
Genetics in Medicine (2021) Vol. 23, Iss. 8, pp. 1381-1390
Open Access | Times Cited: 462
Psychiatric diagnosis and treatment in the 21st century: paradigm shifts versus incremental integration
Dan J. Stein, Steven Shoptaw, Daniel Vigo, et al.
World Psychiatry (2022) Vol. 21, Iss. 3, pp. 393-414
Open Access | Times Cited: 171
Recommendations for Clinical CYP2D6 Genotyping Allele Selection
Victoria M. Pratt, Larisa H. Cavallari, Andria L. Del Tredici, et al.
Journal of Molecular Diagnostics (2021) Vol. 23, Iss. 9, pp. 1047-1064
Open Access | Times Cited: 117
Pharmacogenomic Testing and Depressive Symptom Remission: A Systematic Review and Meta‐Analysis of Prospective, Controlled Clinical Trials
Lisa Brown, Joseph D. Stanton, Kanika Bharthi, et al.
Clinical Pharmacology & Therapeutics (2022) Vol. 112, Iss. 6, pp. 1303-1317
Open Access | Times Cited: 71
Comorbid Chronic Pain and Depression: Shared Risk Factors and Differential Antidepressant Effectiveness
William H. Roughan, Adrián I. Campos, Luis M. García‐Marín, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 91
The genetic basis of major depression
Kimberley Kendall, E. Van Assche, Till F. M. Andlauer, et al.
Psychological Medicine (2021) Vol. 51, Iss. 13, pp. 2217-2230
Open Access | Times Cited: 57
Pharmacogenomics in treatment of depression and psychosis: an update
Marin M. Jukić, F. Milosavljević, Espen Molden, et al.
Trends in Pharmacological Sciences (2022) Vol. 43, Iss. 12, pp. 1055-1069
Open Access | Times Cited: 42
Overview of therapeutic drug monitoring and clinical practice
Zijun Fang, He Zhang, Jiuchuan Guo, et al.
Talanta (2023) Vol. 266, pp. 124996-124996
Closed Access | Times Cited: 32
Effect of pharmacogenomics testing guiding on clinical outcomes in major depressive disorder: a systematic review and meta-analysis of RCT
Xinrui Wang, Chenfei Wang, Yi Zhang, et al.
BMC Psychiatry (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 22
How Real-World Data Can Facilitate the Development of Precision Medicine Treatment in Psychiatry
Elise Koch, Antonio F. Pardiñas, Kevin S. O’Connell, et al.
Biological Psychiatry (2024) Vol. 96, Iss. 7, pp. 543-551
Open Access | Times Cited: 12
Pharmaco-Multiomics: A New Frontier in Precision Psychiatry
Dhoha Dhieb, Kholoud Bastaki
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1082-1082
Open Access | Times Cited: 1
What Are the Barriers and Enablers to the Implementation of Pharmacogenetic Testing in Mental Health Care Settings?
Adam Jameson, Beth Fylan, Greg C. Bristow, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 46
Economic evaluation in psychiatric pharmacogenomics: a systematic review
Kariofyllis Karamperis, Maria Koromina, Panagiotis Papantoniou, et al.
The Pharmacogenomics Journal (2021) Vol. 21, Iss. 4, pp. 533-541
Open Access | Times Cited: 45
Genophenotypic Factors and Pharmacogenomics in Adverse Drug Reactions
Ramón Cacabelos, Vinogran Naidoo, Lola Corzo, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 24, pp. 13302-13302
Open Access | Times Cited: 44
Clinical utility of combinatorial pharmacogenomic testing in depression: A Canadian patient- and rater-blinded, randomized, controlled trial
Arun K. Tiwari, Clement C. Zai, C. Anthony Altar, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 37
The emergence, implementation, and future growth of pharmacogenomics in psychiatry: a narrative review
Chad A. Bousman, Abdullah Al Maruf, Diogo Marques, et al.
Psychological Medicine (2023) Vol. 53, Iss. 16, pp. 7983-7993
Open Access | Times Cited: 19
Updates in SJS/TEN: collaboration, innovation, and community
Madeline Marks, Ramya Krishna Botta, Riichiro Abe, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 19
Pharmacogenomics: A road ahead for precision medicine in psychiatry
Antonio F. Pardiñas, Michael J. Owen, James Walters
Neuron (2021) Vol. 109, Iss. 24, pp. 3914-3929
Open Access | Times Cited: 39
Practical Strategies Using Medical Cannabis to Reduce Harms Associated With Long Term Opioid Use in Chronic Pain
Caroline A. MacCallum, Lauren Eadie, Alasdair M. Barr, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 36
Consensus on potential biomarkers developed for use in clinical tests for schizophrenia
Ping Lin, Junyu Sun, Xiaoyan Lou, et al.
General Psychiatry (2022) Vol. 35, Iss. 1, pp. e100685-e100685
Open Access | Times Cited: 25
Genetics in the ADHD Clinic: How Can Genetic Testing Support the Current Clinical Practice?
Lívia Balogh, Attila J. Pulay, János Réthelyi
Frontiers in Psychology (2022) Vol. 13
Open Access | Times Cited: 22
A Comprehensive Analysis of 21 Actionable Pharmacogenes in the Spanish Population: From Genetic Characterisation to Clinical Impact
Rocío Núñez‐Torres, Guillermo Pita, María Peña-Chilet, et al.
Pharmaceutics (2023) Vol. 15, Iss. 4, pp. 1286-1286
Open Access | Times Cited: 13
Antidepressants and Weight Gain: An Update on the Evidence and Clinical Implications
Lauren Moss, Marci Laudenslager, Kristine J. Steffen, et al.
Current Obesity Reports (2025) Vol. 14, Iss. 1
Closed Access
The Use of Pharmacogenomics in Mental Health
Trina Walker, Crystal Dodson, Chad A. Bousman
Nursing Clinics of North America (2025)
Closed Access
Emerging trends in therapeutics and diagnostics: Perspectives on the 2024 AMCP Foundation Survey
Catherine M. Lockhart, Michael Manolakis
Journal of Managed Care & Specialty Pharmacy (2025) Vol. 31, Iss. 1-b Suppl, pp. S15-S19
Closed Access
Page 1 - Next Page

Scroll to top